We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.79B
AUM Growth
+$579M
Cap. Flow
+$109M
Cap. Flow %
1.4%
Top 10 Hldgs %
71.8%
Holding
138
New
7
Increased
44
Reduced
52
Closed
7

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$349M
2
PG icon
Procter & Gamble
PG
+$148M
3
KO icon
Coca-Cola
KO
+$22.7M
4
HDB icon
HDFC Bank
HDB
+$9.79M
5
PFE icon
Pfizer
PFE
+$5.65M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$216M
2
C icon
Citigroup
C
+$118M
3
V icon
Visa
V
+$63.9M
4
DXCM icon
DexCom
DXCM
+$5.47M
5
KTWO
K2M Group Holdings, Inc
KTWO
+$5.35M

Sector Composition

Rank Sector Weight
1 Financials 26.45%
2 Consumer Discretionary 18.43%
3 Healthcare 14.45%
4 Communication Services 13.53%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESPR
126
DELISTED
Esperion Therapeutics
ESPR
$222K ﹤0.01%
4,999
+695
+16% +$31.9K
ICPT
127
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$183K ﹤0.01%
1,446
+202
+16% +$21.4K
LXRX icon
128
Lexicon Pharmaceuticals
LXRX
$1.03B
$171K ﹤0.01%
16,037
+2,224
+16% +$25.5K
ACAD icon
129
Acadia Pharmaceuticals
ACAD
$4.43B
$169K ﹤0.01%
8,147
+1,115
+16% +$17.5K
RDUS
130
DELISTED
Radius Health, Inc.
RDUS
$131K ﹤0.01%
7,336
+1,057
+17% +$23.9K
SNDX icon
131
Syndax Pharmaceuticals
SNDX
$1.69B
$107K ﹤0.01%
13,227
+2,074
+19% +$14.8K
INGR icon
132
Ingredion
INGR
$6.27B
-8,254
Closed -$913K
PM icon
133
Philip Morris
PM
$297B
-2,670,730
Closed -$216M
VTVT icon
134
vTv Therapeutics
VTVT
$127M
-1,205
Closed -$74K
WBA
135
DELISTED
Walgreens Boots Alliance
WBA
-18,947
Closed -$1.14M
ZBH icon
136
Zimmer Biomet
ZBH
$18.2B
-42,055
Closed -$4.55M
ZVRA icon
137
Zevra Therapeutics
ZVRA
$562M
-25,000
Closed -$2.6M
KTWO
138
DELISTED
K2M Group Holdings, Inc
KTWO
-237,603
Closed -$5.35M

Similar funds

C WorldWide Group's Q3 2018 Portfolio in Review

As of Q3 2018, C WorldWide Group held 138 positions worth $7.79B, up 8% from $7.21B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

C WorldWide Group's Q3 2018 filing shows 7 new, 44 increased, 52 reduced and 7 closed positions. Its largest new stake was ExxonMobil: 4,273,004 shares worth $363M. The largest sale was Philip Morris, an estimated $216M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q3 2018 buy was ExxonMobil: 4,273,004 shares worth $363M.
  • C WorldWide Group added most to Procter & Gamble in Q3 2018, an estimated $148M increase.
  • C WorldWide Group's biggest Q3 2018 reduction was Citigroup, cutting an estimated $118M.
  • C WorldWide Group fully exited Philip Morris in Q3 2018, selling an estimated $216M.
  • C WorldWide Group's ten largest holdings make up 72% of its $7.79B portfolio in Q3 2018.
  • C WorldWide Group opened 7 new positions and closed 7 in Q3 2018.
  • C WorldWide Group's portfolio value rose 8% quarter-over-quarter to $7.79B.

Based on C WorldWide Group's 13F filing for Q3 2018, filed 5 Nov 2018.